Comunicati Stampa
Cibi e Bevande

FIG makes a strategic investment in Elitepharm Laboratoires and brings AI to nutraceuticals

From research and development to the manufacturing of private label food supplements, Elitepharm provides solutions for all projects, from small to large series. From research and development to the manufacturing of private label food supplements, Elitepharm provides solutions for all projects, from small to large series. Narek Sirakanayan, President & CEO of Freedom International Group, said: " Freedom is making a strategic investment in the healthcare sector. We have two businesses,...
VIENNA, (informazione.news - comunicati stampa - cibi e bevande)

From research and development to the manufacturing of private label food supplements, Elitepharm provides solutions for all projects, from small to large series.

Narek Sirakanayan, President & CEO of Freedom International Group, said: " . " 

The partnership signed by Narek Sirakanyan and Gérard Strauch, President and CEO of Elitepharm, represents a logical integration as Project V is producing its products, 40 different types, at Elitepharm.

This investment marks a new phase in the industrialization and expansion of Elitepharm Laboratoires, which now aims to become a leading player in Europe , with targeted revenues of 50 million euros by 2029. Today Elitepharm produces about 25 million capsules per month and the target is to double production.

The partnership is based on a shared vision of innovation and industrial excellence. Gérard Strauch, with extensive experience in the dietary supplements sector, has successfully positioned Elitepharm as a company recognized for its expertise, scientific rigor, and ability to anticipate market trends. He has structured the company to meet the growing demands of the sector, emphasizing quality and flexibility.

Thanks to FIG's investment, Elitepharm Laboratoires will accelerate its commercial and industrial development and benefit from FIG's marketing and PR know how. This expansion is based on several strategic areas:

Sirakanyan:

" says Gérard Strauch.

With this alliance, FIG and Elitepharm reaffirm their commitment to building a strong and sustainable industrial model, dedicated to health and well-being across Europe .

Press contact:

Raffaello Porro
mobile. +393351015456
raffaello.porro@studiorpr.com

Photo - https://mma.prnewswire.com/media/2620651/Freedom_International_Group.jpg
Logo - https://mma.prnewswire.com/media/2606779/FIG_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/fig-makes-a-strategic-investment-in-elitepharm-laboratoires-and-brings-ai-to-nutraceuticals-302377178.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili